Northwire Canada EditionThursday, October 15, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4% GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4%
Earnings Routine +

Promino Nutritional Sciences Reports Fiscal 2025 Results, Delivering Revenue Growth and Improved Financial Performance

Promino Confirms Turnaround Trajectory But Cash Burn Remains Critical Risk

By The Northwire Desk — AI Analysis May 04, 2026 · 07:01 MUSL · 0.035 Promino Nutritional Sciences Inc
Executive Summary
  • Fiscal 2025 Results: Revenue grew to over $2.1 million from approximately $260,600 in the prior year (8x growth). Net loss decreased to $3.0 million from $7.1 million.
  • Governance Cleanup: Cease-trade order revoked; enhanced internal controls implemented; 2024 financial statements restated for transparency regarding share-based payments and liabilities.
  • Operations: Expanded distribution of Rejuvenate Muscle Health™; initiated production run of 3.5 million servings across four flavors (Mango, Grape, etc.).
  • Management Commentary: CEO Vito Sanzone emphasizes disciplined growth, expanded distribution, and strengthened operational foundation following financial infrastructure investments.
Material Impact
  • Revenue Validation: The $2.1 million revenue figure validates the December 2025 announcement of $1.88 million YTD sales through October. This confirms the commercial traction was not a one-off but sustained growth into Q4.
  • Loss Reduction: While losses decreased significantly ($7.1M to $3.0M), the company remains unprofitable with expenses exceeding revenue by ~$1.3 million. This necessitates continued capital raises, which is consistent with historical financing patterns.
  • Governance Risk Mitigation: The revocation of the cease-trade order and restatement completion removes a major regulatory overhang that previously suppressed valuation. However, this was largely anticipated following the December 2025 trading halt lift.
  • Financing Context: The news aligns with the April 2026 private placement ($1.2M) intended to fund inventory production. The earnings confirm the capital is being deployed into revenue-generating assets (inventory).
  • Market Expectation: Given the December 2025 guidance and subsequent financing rounds, this result is in line with expectations rather than a surprise upside that would materially re-rate the stock.
MUSL · Price
Company Overview
  • Company: Promino Nutritional Sciences Inc., listed on the Canadian Securities Exchange (CSE).
  • Flagship Product: Rejuvenate Muscle Health™. An amino-acid formulation marketed for muscle preservation, specifically targeting consumers using GLP-1 weight-loss therapies who need to maintain lean mass.
  • Product Format: Currently powder sticks; Ready-to-Drink (RTD) version planned for Q3 2026.
  • Distribution: Approximately 10,000 retail doors in North America as of March/April 2026 updates. Strong Amazon presence (>4,000 units/month).
  • Strategic Partnerships: NCAA Division I athlete platform with Virginia Military Institute (VMI) launched April 2026 to validate efficacy and build brand credibility.
Read the original news release →

More from Promino Nutritional Sciences Inc

Jun 30, 2026 · 18:46

Former CEO lawsuit adds minor legal friction to a company battling severe liquidity constraints and inventory depletion.

Regulatory Jun 18, 2026 · 06:01

Promino Expands U.S. NCAA Athlete Platform with Multi-Sport NIL Agreement with Every True Tiger

Financings Jun 09, 2026 · 06:01

Promino Launches Muscle Health Research Initiative Targeting GLP-1 Weight Management Market

Other Jun 05, 2026 · 22:04

Promino Announces Settlements and Amendments of Convertible Debentures

Financings Jun 04, 2026 · 06:01

Promino Nutritional Sciences Inc.

M&A / Property Jun 02, 2026 · 06:01

Promino(TM) Delivered to Stanley Cup Final Locker Room as Ambassador Jack Eichel Competes for Championship

M&A / Property